Pei-Hong Wu (Peihong Wu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Ejection Fraction

Signaling Pathway

Squamous Cell Carcinoma

Decision Making

Top Venues

Cancer medicine

British journal of cancer

Cancer immunology, immunotherapy : CII

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Chao An, Ran Wei, Wang Yao, Wenwen Han, Wang Li, Ge Shi, Pei-Hong Wu
Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study. Cancer medicine 13 (11) (2024)
Chao An, Ran Wei, Wang Yao, Wenwen Han, Wang Li, Ge Shi, Pei-Hong Wu
Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study. Cancer medicine 13 (11) (2024)
Chao An, Ran Wei, Wendao Liu, Yan Fu, Xiaolong Gong, Chengzhi Li, Wang Yao, Mengxuan Zuo, Wang Li, Yansheng Li, Fatian Wu, Kejia Liu, Dong Yan, Pei-Hong Wu, Jianjun Han
Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study. British journal of cancer (2024)
Chao An, Ran Wei, Wang Yao, Wenwen Han, Wang Li, Ge Shi, Pei-Hong Wu
Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study. Cancer medicine 13 (11) (2024)
Chao An, Ran Wei, Wendao Liu, Yan Fu, Xiaolong Gong, Chengzhi Li, Wang Yao, Mengxuan Zuo, Wang Li, Yansheng Li, Fatian Wu, Kejia Liu, Dong Yan, Pei-Hong Wu, Jianjun Han
Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study. British journal of cancer 131 (5) (2024)
Chao An, Yan Fu, Wang Li, Mengxuan Zuo, Pei-Hong Wu
Postprogression treatment of lenvatinib plus PD-1 inhibitor in advanced hepatocellular carcinoma refractory to HAIC. Cancer (2023)
Feng Shi, Ming Wu, Shan-Shan Lian, Zhi-Qiang Mo, Qing Gou, Rong-De Xu, Hui-Lan Li, Zhi-Mei Huang, Pei-Hong Wu, Xiao-Ming Chen
Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-term Outcomes. Radiology 293 (3) (2019)
Tao Huang, Qi-Feng Chen, Bo-Yang Chang, Lu-Jun Shen, Wang Li, Pei-Hong Wu, Wei-Jun Fan
TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway. Disease markers 2019 (2019)
Boyang Chang, Lujun Shen, Kefeng Wang, Jietian Jin, Tao Huang, Qifeng Chen, Wang Li, Pei-Hong Wu
High number of PD-1 positive intratumoural lymphocytes predicts survival benefit of cytokine-induced killer cells for hepatocellular carcinoma patients. Liver international : official journal of the International Association for the Study of the Liver 38 (8) (2018)
Boyang Chang, Tao Huang, Huajun Wei, Lujun Shen, Duo Zhu, Wenjun He, Qifeng Chen, Huihua Zhang, Yunjian Li, Ruopan Huang, Wang Li, Pei-Hong Wu
The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma. Cancer immunology, immunotherapy : CII 68 (3) (2018)